{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:33:08Z","timestamp":1773293588767,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/chi.0b013e318190043e","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T03:14:18Z","timestamp":1229310858000},"page":"71-78","source":"Crossref","is-referenced-by-count":41,"title":["Early Prediction of Acute Antidepressant Treatment Response and Remission in Pediatric Major Depressive Disorder"],"prefix":"10.1016","volume":"48","author":[{"given":"Rongrong","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Emslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taryn","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nakonezny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carroll","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/CHI.0b013e318190043e_bib1","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","article-title":"Report by the ACNP Task Force on response and remission in major depressive disorder","volume":"31","author":"Rush","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1097\/CHI.0b013e318190043e_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1469-7610.2005.01467.x","article-title":"Review of the efficacy and safety of antidepressants in youth depression","volume":"46","author":"Cheung","year":"2005","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Treatment for Adolescents With Depression Study (TADS) Team: fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents With Depression Study (TADS) randomized controlled Trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"key":"10.1097\/CHI.0b013e318190043e_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/chi.0b013e31804a859b","article-title":"The Texas Childhood Medication Algorithm Project: update from the Texas consensus conference panel on medication treatment for the treatment of childhood major depressive disorder","volume":"46","author":"Hughes","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0163-8343(92)90093-P","article-title":"The development of clinical practice guidelines for the diagnosis and treatment of depression","volume":"14","author":"Rush","year":"1992","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameters for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","author":"American Academy of Child and Adolescent Psychiatry","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.57.1.29","article-title":"Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder","volume":"57","author":"Birmaher","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/01.chi.0000240838.78984.e2","article-title":"Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS)","volume":"45","author":"Curry","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0165-0327(98)00205-5","article-title":"Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study","volume":"54","author":"Kowatch","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1097\/CHI.0b013e318190043e_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/gps.1804","article-title":"Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder","volume":"22","author":"Saghafi","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.nmd.0000207358.15230.80","article-title":"Does the clinical course of depression determine improvement in symptoms and quality of life?","volume":"194","author":"Moses","year":"2006","journal-title":"J Nerv Ment Dis"},{"key":"10.1097\/CHI.0b013e318190043e_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2006.03.014","article-title":"Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder","volume":"149","author":"Papakostas","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1097\/CHI.0b013e318190043e_bib13","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0149-2918(03)80220-5","article-title":"Tolerability and adherence issues in antidepressant therapy","volume":"25","author":"Masand","year":"2003","journal-title":"Clin Ther"},{"key":"10.1097\/CHI.0b013e318190043e_bib14","series-title":"Children's Depression Rating Scale-Revised. (CDRS-R)","author":"Poznanski","year":"1996"},{"key":"10.1097\/CHI.0b013e318190043e_bib15","series-title":"ECDEU Assessment Manual for Psychopharmacology Revised","author":"Guy","year":"1976"},{"key":"10.1097\/CHI.0b013e318190043e_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/appi.ajp.2007.07091453","article-title":"Fluoxetine vs. placebo to prevent relapse of MDD in children and Adolescents","volume":"165","author":"Emslie","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib17","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1097\/CHI.0b013e318190043e_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archpsyc.1986.01800050019002","article-title":"The family history approach to diagnosis","volume":"43","author":"Andreasen","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"10.1097\/CHI.0b013e318190043e_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1097\/CHI.0b013e318190043e_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0925-4927(99)00034-7","article-title":"Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine","volume":"91","author":"Brody","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1097\/CHI.0b013e318190043e_bib24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.biopsych.2007.10.009","article-title":"Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings","volume":"63","author":"Bruder","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib25","first-page":"474","article-title":"Limbic-cortical dysregulation: a proposed model of depression","volume":"9","author":"Mayberg","year":"1997","journal-title":"J Neuropsychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mp.4000425","article-title":"Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine","volume":"3","author":"Smeraldi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1097\/CHI.0b013e318190043e_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S1092852900020666","article-title":"Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine?","volume":"12","author":"Mayes","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1097\/CHI.0b013e318190043e_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856708601720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856708601720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:17:32Z","timestamp":1738801052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856708601720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0890856708601720"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e318190043e","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1160666.622058","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1160666.622412","asserted-by":"object"}]},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}